Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet? - Wikidata - wikimedia - TriplyDB

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

http://www.wikidata.org/entity/Q38871976

about

Resistant Hypertension: Mechanisms and Treatment.Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners

P2860

Q38734859-B4DCEB7E-339C-49DC-B317-CE60B6A73625 Q56981925-93BB6974-13FD-4940-A4AA-C23C9481A36C

P2860

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

http://www.wikidata.org/entity/Q38871976

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

@en

type

label

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

@en

prefLabel

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

@en

P1433

Q38871976-7128D788-50B7-4803-8783-263E8B46A84E

P1476

Q38871976-B25FBFA5-3D0E-4C6E-8D95-5B50776171C0

P2093

Q38871976-139C0897-5EAD-4F7D-9CEA-DAFEA2C784DB

Q38871976-38816805-E9F4-4301-B914-EF951BCAA6D0

Q38871976-439E861B-535B-469A-BFE4-9A47D030D605

Q38871976-72B2675C-1B01-47FE-8B87-A11EF18F7B8E

Q38871976-853A67B3-A8D0-40F1-800B-A9304CF309E1

Q38871976-A2A9BBAB-6628-4DDD-B0F9-0F4F69FE3FC0

P2860

Q38871976-043A1EFC-94BF-4999-8687-FE13F71EDE23

Q38871976-060968FD-DC07-4242-B7B7-274BB45AD0E8

Q38871976-07819989-B656-4F21-8126-0EAEA4414FFF

Q38871976-1493EDAA-28A3-4B6F-93AC-9ACA4CBC6252

Q38871976-16CC25DB-C090-44F7-B249-1E25834CE101

Q38871976-18ED7EB5-86AE-43EF-B61A-E96CA6C5FAE6

Q38871976-1C3720AC-AFDE-4DF3-A037-0AE43A0BD7A1

Q38871976-1FBC404A-6BFB-495B-81F0-6F3423637AFA

Q38871976-21580B97-442B-4B0C-9C2A-06B3CEBF0212

Q38871976-22126B65-C7FB-4BB0-B78A-ADFB9F8CF512

P2888

Q38871976-F06A65E5-A5FA-4AAD-AF35-1027943A7BFD

P304

Q38871976-5AD24471-4BAC-46BF-B3BC-A518057153DF

P31

Q38871976-65A3552F-4F90-4FDE-B36E-ABAB7B68691E

P356

Q38871976-1F3580B7-31A8-45ED-ACC4-BC5D1217EC14

P433

Q38871976-127D4728-3DF1-448E-B652-C6927331C1DB

P478

Q38871976-BBD3F91B-E52E-4224-936C-B287A521841E

P50

Q38871976-18CFE1CD-F790-4C83-B10E-7C3FAD48DEDF

Q38871976-8E44DBC1-73DA-4203-936C-025AF405DB16

Q38871976-C0174449-B470-4335-A692-0D9CA1E8D82F

Q38871976-D02B4844-F9D3-4D12-B9ED-5FF737CD8D13

P577

Q38871976-97729ADB-0161-468A-AAC2-B82560C90717

P6179

Q38871976-4EFC6FAD-1BDF-4E0E-A02D-99C13E23C921

P698

Q38871976-2C39B97B-0043-48BC-9246-2CD3C6DDA534

P921

Q38871976-89B09DBB-45ED-4068-8B1B-867B40897452

P356

S11906-017-0728-Z

P1433

Current Hypertension Reports

P1476

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

@en

P2093

Cynthia Gregory

http://www.w3.org/2001/XMLSchema#string

Dagmara Hering

http://www.w3.org/2001/XMLSchema#string

Graham S Hillis

http://www.w3.org/2001/XMLSchema#string

Greg Perry

http://www.w3.org/2001/XMLSchema#string

Hamish Cg Prosser

http://www.w3.org/2001/XMLSchema#string

Mark Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Carotid Baroreceptor Stimulation and Arteriovenous Shunts for Resistant Hypertension

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

A controlled trial of renal denervation for resistant hypertension

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study

The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

P2888

s11906-017-0728-z

P304

30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11906-017-0728-Z

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Markus P. Schlaich

Johan B. Rosman

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084033382

http://www.w3.org/2001/XMLSchema#string

P698

28349377

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy